We previously demonstrated that SM inhibited the growth of human lung cancer cells through inactivation of phosphatidylinositol 3‐kinase (PI3‐K)/Akt signaling pathway and reduction of transcription factor SP1 and p65 proteins. The gene discussed is SP1; the disease is lung carcinoma.